Work

Efficacy of Elecsys® HCV Duo in diagnosing hepatitis C virus-positive patients

Year: 2025

Type: article

Abstract: Elecsys® HCV Duo is a new antigen-antibody combination test for hepatitis C virus. This study evaluated its usefulness in diagnosing patients with hepatitis C using pretreatment serum samples from 100 patients with chronic hepatitis C who underwent direct-acting antiviral therapy. Results of HCV Duo testing revealed positive rates in HCV Ab and HCV Ag at 100% and 79%, respectively. The HCV Duo test is effective regardless of gender, age, and body mass index. Thus, Elecsys® HCV Duo can diagnose hepatitis C in approximately 80% of patients without measuring HCV-RNA. It can also identify HCV carriers on the same day of testing and may help eliminate HCV through early consultation with hepatologists and gastroenterologists.

Source: Kanzo

DOI: 10.2957/kanzo.66.411

Authors: Keisuke Amano, Tomoya Sano, Tatsuya Ide, Shigemune Bekki, Dan Nakano, Teruko Arinaga-Hino, Takumi Kawaguchi

Institutions: Kurume University, Kurume University Hospital, Kurume University Medical Center

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4414107156

FWCI: 0.497

Cites: 5

Cited by: 1

Related to: 10